When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 22 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • pain
  • dyspnoea

Other diagnostic factors

  • signs of impaired oxygenation
  • paradoxical chest wall motion

Risk factors

  • blunt chest trauma
  • cardiopulmonary resuscitation (CPR)
  • physical abuse in children
  • osteoporosis
  • age >65 years
  • participation in sport
  • primary bone tumours
  • metastatic bone tumours
  • severe cough

Diagnostic investigations

1st investigations to order

  • CXR
  • CT chest
  • extended focused assessment with sonography

Investigations to consider

  • CT of head, cervical spine, abdomen, and pelvis
  • echocardiography
  • skeletal survey and CT head (children)

Treatment algorithm

Contributors

Expert advisers

Michael Barrett, MBChB, FRCS (Tr & Orth), PG Cert Med Ed

Consultant Trauma and Orthopaedic Surgeon

Cambridge University Hospitals NHS Foundation Trust

Cambridge

UK

Disclosures

MB is a director of Orthohub.xyz, an online education platform for orthopaedic surgeons. Orthohub.xyz receives sponsorship from the healthcare industry.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Peter Cundy, MBBS, FRACS

Associate Professor

Discipline of Orthopaedics & Trauma

University of Adelaide

Paediatric Orthopaedic Surgeon

Women's and Children's Hospital

Adelaide

Australia

Nicole Williams, BMedSc (hons I), BMed, Grad Cert Sports Med, FRACS (Ortho)

Associate Professor

Orthopaedics and Trauma

University of Adelaide

Head of Orthopaedic Surgery and Major Trauma Service Co-Director

Women's and Children's Hospital

Adelaide

Australia

Disclosures

PC is on the boards of MIGA (medical indemnity insurance) and Orthopaedics SA. He owns stock though a personal superannuation fund. PC’s hospital, the Women's & Children's Hospital, Adelaide, receives institutional support from medical supply companies for salary of research scientists. PC received payment from a medical supplier for two lectures on wound dressings in 2017. PC declares that none of the above are relevant to the Rib fractures topic and that he receives no other money from suppliers. NW’s hospital, the Women's & Children's Hospital, Adelaide, receives institutional research support from medical supply companies and BioMarin Pharmaceutical Inc.

Peer reviewers

Douglas West, BSc(Hons), MB, ChB, FRCS(CTh), Dip Epidemiol (Lond)

Consultant Thoracic Surgeon

University Hospitals Bristol and Weston NHS Foundation Trust

Bristol

UK

Biography

DW is Thoracic Surgery Audit Lead and Audit Committee Co-Chair, the Society for Cardiothoracic Surgery; Cardiothoracic National Clinical Lead, Getting it Right First Time (GIRFT), NHS England Improvement; Board Member, Cardiothoracic Specialty Specific Group, the Royal College of Surgeons of Edinburgh. DW is Co-Chair, Lung Cancer Guideline Update Committee, NICE (2019) and Member, Lung Cancer Quality Standards Committee, NICE (2019). DW has been a member of the NHS England Clinical Expert Group on Lung Cancer.

Disclosures

DW has received speaker’s fees from AstraZeneca for events related to lung cancer care; research grants and speaker’s fees from Medtronic, a medical devices company; speaker’s fees and travel expenses from Ethicon, a medical devices company, for events related to training in thoracic and spinal surgery; and reimbursement of travel expenses from Bristol Myers Squibb for events related to lung cancer. DW has edited patient education materials (unpaid) for the Roy Castle Foundation, and has been reimbursed by it for travel expenses incurred attending meetings of the NHS England Clinical Expert Group in Lung Cancer.

Use of this content is subject to our disclaimer